COMPOSITIONS AND METHODS FOR TREATING LATE STAGE LUNG CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20190276543A1
SERIAL NO

15915359

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are methods for treating late stage (e.g., clinical stage III or IV), unresectable non-small-cell lung cancer (NSCLC) with an antibody that inhibits PD1/PD-L1 activity in a patient identified as having not progressed following definitive chemoradiation therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTRAZENECA AB151 85 SÖDERTÄLJE SE-151 85

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ballas, Marc Wilmington, US 3 14
Dovedi, Simon Cambridge, GB 9 20
Melillo, Giovanni Wilmington, US 2 0
Stewart, Ross Cambridge, GB 4 22

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation